Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
41
REX Quote, Financials, Valuation and Earnings
Last price:
$53.21
Seasonality move
:
2.57%
Day range:
$53.06 - $54.71
52-week range:
$33.45 - $55.36
Dividend yield:
0%
P/E ratio:
16.53x
P/S ratio:
1.46x
P/B ratio:
1.63x
Volume:
81.1K
Avg. volume:
121K
1-year change:
9.73%
Market cap:
$876.5M
Revenue:
$642.5M
EPS (TTM):
$3.22
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $372.7M | $774.8M | $855M | $833.4M | $642.5M | |
| Revenue Growth (YoY) | -10.78% | 107.91% | 10.35% | -2.53% | -22.91% | |
| Cost of Revenues | $353.1M | $684.2M | $806.4M | $735.2M | $551M | |
| Gross Profit | $19.5M | $90.6M | $48.6M | $98.2M | $91.5M | |
| Gross Profit Margin | 5.24% | 11.7% | 5.68% | 11.79% | 14.24% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $17.6M | $21.5M | $22.8M | $29.4M | $27.1M | |
| Other Inc / (Exp) | $500K | $6.6M | $8.7M | $13.9M | $9.4M | |
| Operating Expenses | $17.6M | $21.5M | $22.8M | $29.4M | $27.1M | |
| Operating Income | $1.9M | $69.1M | $25.8M | $68.8M | $64.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $4.2M | $75.8M | $47.5M | $98.5M | $92.9M | |
| Earnings of Discontinued Ops. | $1.1M | $4.4M | -- | -- | -- | |
| Income Tax Expense | -$546K | $19M | $9.5M | $22.6M | $21.4M | |
| Net Income to Company | $4.8M | $56.8M | $37.9M | $75.9M | $71.5M | |
| Minority Interest in Earnings | -$2.9M | -$8.8M | -$10.2M | -$15M | -$13.3M | |
| Net Income to Common Excl Extra Items | $3M | $52.4M | $27.7M | $60.9M | $58.2M | |
| Basic EPS (Cont. Ops) | $0.16 | $2.92 | $1.57 | $3.49 | $3.30 | |
| Diluted EPS (Cont. Ops) | $0.16 | $2.92 | $1.57 | $3.47 | $3.30 | |
| Weighted Average Basic Share | $18.5M | $17.9M | $17.6M | $17.5M | $17.6M | |
| Weighted Average Diluted Share | $18.5M | $17.9M | $17.6M | $17.6M | $17.6M | |
| EBITDA | $25.4M | $92.7M | $49.1M | $91.9M | $86M | |
| EBIT | $1.9M | $69.1M | $25.8M | $68.8M | $64.3M | |
| Revenue (Reported) | $372.7M | $774.8M | $855M | $833.4M | $642.5M | |
| Operating Income (Reported) | $1.9M | $69.1M | $25.8M | $68.8M | $64.3M | |
| Operating Income (Adjusted) | $1.9M | $69.1M | $25.8M | $68.8M | $64.3M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $164M | $194.2M | $212.7M | $161.2M | $158.3M | |
| Revenue Growth (YoY) | 97.05% | 18.4% | 9.52% | -24.2% | -1.79% | |
| Cost of Revenues | $144.6M | $182.3M | $202.5M | $146.8M | $144M | |
| Gross Profit | $19.5M | $11.9M | $10.2M | $14.5M | $14.3M | |
| Gross Profit Margin | 11.87% | 6.13% | 4.78% | 8.96% | 9.06% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $9.9M | $5.2M | $5.8M | $6.1M | $5.9M | |
| Other Inc / (Exp) | $570K | $2M | $1.5M | $1.7M | $1M | |
| Operating Expenses | $9.9M | $5.2M | $5.8M | $6.1M | $5.9M | |
| Operating Income | $9.6M | $6.7M | $4.4M | $8.3M | $8.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $10.2M | $8.8M | $8.7M | $16M | $13.6M | |
| Earnings of Discontinued Ops. | $515K | -- | -- | -- | -- | |
| Income Tax Expense | $2.2M | $1.8M | $2M | $3.7M | $3M | |
| Net Income to Company | $8M | $7M | $6.7M | $12.3M | $10.7M | |
| Minority Interest in Earnings | -$694K | -$1.8M | -$1.5M | -$2.1M | -$2M | |
| Net Income to Common Excl Extra Items | $7.8M | $5.2M | $5.2M | $10.2M | $8.7M | |
| Basic EPS (Cont. Ops) | $0.43 | $0.29 | $0.30 | $0.58 | $0.51 | |
| Diluted EPS (Cont. Ops) | $0.43 | $0.29 | $0.30 | $0.58 | $0.51 | |
| Weighted Average Basic Share | $18M | $17.8M | $17.4M | $17.5M | $16.9M | |
| Weighted Average Diluted Share | $18M | $17.8M | $17.4M | $17.7M | $16.9M | |
| EBITDA | $15.5M | $12.6M | $10.2M | $14.2M | $13.4M | |
| EBIT | $9.6M | $6.7M | $4.4M | $8.3M | $8.4M | |
| Revenue (Reported) | $164M | $194.2M | $212.7M | $161.2M | $158.3M | |
| Operating Income (Reported) | $9.6M | $6.7M | $4.4M | $8.3M | $8.4M | |
| Operating Income (Adjusted) | $9.6M | $6.7M | $4.4M | $8.3M | $8.4M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $453.6M | $805M | $873.5M | $781.9M | $639.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $408.2M | $721.9M | $826.6M | $679.4M | $548.2M | |
| Gross Profit | $45.3M | $83.1M | $46.9M | $102.5M | $91.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $22.8M | $16.8M | $23.4M | $29.7M | $27M | |
| Other Inc / (Exp) | $1.5M | $8M | $8.3M | $14.1M | $8.7M | |
| Operating Expenses | $22.8M | $16.8M | $23.4M | $29.7M | $27M | |
| Operating Income | $22.5M | $66.2M | $23.5M | $72.8M | $64.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $25.2M | $74.5M | $47.3M | $105.8M | $90.5M | |
| Earnings of Discontinued Ops. | $515K | $3.7M | -- | -- | -- | |
| Income Tax Expense | $3.1M | $18.7M | $9.7M | $24.3M | $20.7M | |
| Net Income to Company | $21.2M | $55.8M | $37.7M | $81.5M | $69.9M | |
| Minority Interest in Earnings | -$4.2M | -$9.8M | -$9.9M | -$15.6M | -$13.2M | |
| Net Income to Common Excl Extra Items | $19.5M | $49.8M | $27.8M | $65.9M | $56.7M | |
| Basic EPS (Cont. Ops) | $1.02 | $2.78 | $1.58 | $3.76 | $3.24 | |
| Diluted EPS (Cont. Ops) | $1.02 | $2.78 | $1.58 | $3.75 | $3.22 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $45.3M | $89.8M | $46.6M | $96M | $85.2M | |
| EBIT | $22.5M | $66.2M | $23.5M | $72.8M | $64.4M | |
| Revenue (Reported) | $453.6M | $805M | $873.5M | $781.9M | $639.6M | |
| Operating Income (Reported) | $22.5M | $66.2M | $23.5M | $72.8M | $64.4M | |
| Operating Income (Adjusted) | $22.5M | $66.2M | $23.5M | $72.8M | $64.4M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $164M | $194.2M | $212.7M | $161.2M | $158.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $144.6M | $182.3M | $202.5M | $146.8M | $144M | |
| Gross Profit | $19.5M | $11.9M | $10.2M | $14.5M | $14.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $9.9M | $5.2M | $5.8M | $6.1M | $5.9M | |
| Other Inc / (Exp) | $570K | $2M | $1.5M | $1.7M | $1M | |
| Operating Expenses | $9.9M | $5.2M | $5.8M | $6.1M | $5.9M | |
| Operating Income | $9.6M | $6.7M | $4.4M | $8.3M | $8.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $10.2M | $8.8M | $8.7M | $16M | $13.6M | |
| Earnings of Discontinued Ops. | $515K | -- | -- | -- | -- | |
| Income Tax Expense | $2.2M | $1.8M | $2M | $3.7M | $3M | |
| Net Income to Company | $8M | $7M | $6.7M | $12.3M | $10.7M | |
| Minority Interest in Earnings | -$694K | -$1.8M | -$1.5M | -$2.1M | -$2M | |
| Net Income to Common Excl Extra Items | $7.8M | $5.2M | $5.2M | $10.2M | $8.7M | |
| Basic EPS (Cont. Ops) | $0.43 | $0.29 | $0.30 | $0.58 | $0.51 | |
| Diluted EPS (Cont. Ops) | $0.43 | $0.29 | $0.30 | $0.58 | $0.51 | |
| Weighted Average Basic Share | $18M | $17.8M | $17.4M | $17.5M | $16.9M | |
| Weighted Average Diluted Share | $18M | $17.8M | $17.4M | $17.7M | $16.9M | |
| EBITDA | $15.5M | $12.6M | $10.2M | $14.2M | $13.4M | |
| EBIT | $9.6M | $6.7M | $4.4M | $8.3M | $8.4M | |
| Revenue (Reported) | $164M | $194.2M | $212.7M | $161.2M | $158.3M | |
| Operating Income (Reported) | $9.6M | $6.7M | $4.4M | $8.3M | $8.4M | |
| Operating Income (Adjusted) | $9.6M | $6.7M | $4.4M | $8.3M | $8.4M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $144.5M | $229.8M | $69.6M | $223.4M | $196.3M | |
| Short Term Investments | $36.2M | $25.9M | $211.3M | $155.3M | $162.8M | |
| Accounts Receivable, Net | $19.7M | $25.8M | $25.2M | $23.2M | $21.5M | |
| Inventory | $37.4M | $42.2M | $48.7M | $27M | $31.7M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $12.8M | $12.5M | $13.1M | $17.5M | $17.1M | |
| Total Current Assets | $258.8M | $345.2M | $372.6M | $452.1M | $435.8M | |
| Property Plant And Equipment | $163.5M | $148.8M | $150.7M | $168.6M | $231.7M | |
| Long-Term Investments | $29.5M | $30.6M | $33M | $34.9M | $35.8M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $3.2M | $939K | $1.2M | $1.3M | $1.1M | |
| Total Assets | $479.3M | $550.4M | $579.6M | $664.8M | $720M | |
| Accounts Payable | $16.6M | $32.3M | $34.1M | $42.1M | $28.3M | |
| Accrued Expenses | $4.8M | $10.3M | $9.9M | $15.8M | $12.6M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $4.9M | $4.6M | $5.2M | $4.5M | $5.7M | |
| Other Current Liabilities | $2.7M | $1.4M | $1.6M | $2.2M | $2M | |
| Total Current Liabilities | $30.7M | $50.5M | $54.6M | $66.3M | $50.4M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $42.2M | $62.8M | $68.6M | $77.2M | $76.4M | |
| Common Stock | $299K | $299K | $299K | $299K | $299K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $384.8M | $430.8M | $448M | $513.9M | $560.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $52.4M | $56.8M | $63M | $73.7M | $83.3M | |
| Total Equity | $437.2M | $487.6M | $511M | $587.6M | $643.6M | |
| Total Liabilities and Equity | $479.3M | $550.4M | $579.6M | $664.8M | $720M | |
| Cash and Short Terms | $180.7M | $255.7M | $280.9M | $378.7M | $359.1M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $157.1M | $66.7M | $77.7M | $231.2M | $159.9M | |
| Short Term Investments | $35.9M | $167.3M | $188.1M | $120.6M | $156M | |
| Accounts Receivable, Net | $27.6M | $25.4M | $29.2M | $21.5M | $28M | |
| Inventory | $26.7M | $56.4M | $41.3M | $27.1M | $30.5M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $14.8M | $16M | $16.3M | $16.6M | $17M | |
| Total Current Assets | $269.8M | $342.9M | $361M | $421.6M | $398.8M | |
| Property Plant And Equipment | $160.4M | $147.8M | $149M | $190.6M | $257.2M | |
| Long-Term Investments | $30M | $32.5M | $34.5M | $36.7M | $36.8M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $26M | $24.8M | $22M | $1.2M | $1.1M | |
| Total Assets | $486.1M | $548M | $566.5M | $671M | $693.8M | |
| Accounts Payable | $15.8M | $19.2M | $17.9M | $43.2M | $21M | |
| Accrued Expenses | $4.8M | $8M | $6.6M | $10.2M | $7.6M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $4.6M | $4.5M | $5.1M | $3.7M | $7.2M | |
| Other Current Liabilities | $2.4M | $5.1M | $4.3M | $3.5M | $4.9M | |
| Total Current Liabilities | $29.6M | $38.9M | $36.2M | $62.7M | $42.6M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $40.5M | $53.5M | $49.1M | $72.6M | $74.2M | |
| Common Stock | $299K | $299K | $299K | $299K | $299K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $53M | $58.6M | $63.8M | $73.9M | $83.3M | |
| Total Equity | $445.6M | $494.6M | $517.4M | $598.4M | $619.6M | |
| Total Liabilities and Equity | $486.1M | $548M | $566.5M | $671M | $693.8M | |
| Cash and Short Terms | $193M | $234M | $265.8M | $351.8M | $315.9M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.8M | $56.8M | $37.9M | $75.9M | $71.5M | |
| Depreciation & Amoritzation | $23.5M | $23.6M | $23.3M | $23M | $21.7M | |
| Stock-Based Compensation | $264K | $1.8M | $1.9M | $6.2M | $3.6M | |
| Change in Accounts Receivable | -$7M | -$7.2M | $4.4M | -$789K | $957K | |
| Change in Inventories | -$2.3M | -$4.8M | -$6.5M | $21.8M | -$4.7M | |
| Cash From Operations | $8.6M | $91.7M | $54.8M | $128M | $64.2M | |
| Capital Expenditures | $10.4M | $5.1M | $15.6M | $37.7M | $71.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$20.8M | $5.3M | -$198.5M | $28.4M | -$72.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$19.6M | -$6.6M | -$13M | -- | -$14.7M | |
| Other Financing Activities | -$2.9M | -$4.8M | -$4M | -$4.3M | -$3.7M | |
| Cash From Financing | -$22.4M | -$11.1M | -$17M | -$4.3M | -$18.5M | |
| Beginning Cash (CF) | $180.8M | $146.2M | $232.1M | $71.3M | $223.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$34.6M | $85.9M | -$160.7M | $152.1M | -$27.1M | |
| Ending Cash (CF) | $146.2M | $232.1M | $71.3M | $223.4M | $196.3M | |
| Levered Free Cash Flow | -$1.8M | $86.6M | $39.2M | $90.3M | -$7.1M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $8M | $7M | $6.7M | $12.3M | $10.7M | |
| Depreciation & Amoritzation | $5.9M | $5.9M | $5.8M | $5.9M | $5M | |
| Stock-Based Compensation | $291K | $218K | $612K | $716K | $394K | |
| Change in Accounts Receivable | -$7.9M | $962K | -$6.1M | $2.8M | -$7.4M | |
| Change in Inventories | $11.2M | -$14.2M | $7.4M | -$116K | $1.2M | |
| Cash From Operations | $13.6M | -$17.7M | -$14M | -$2.3M | -$3.5M | |
| Capital Expenditures | $1.3M | $1.5M | $4.2M | $24.8M | $6.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$892K | -$142.8M | $21M | $11.9M | $1.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$32.7M | |
| Other Financing Activities | -$7K | -$1K | -$716K | -$1.8M | -$2M | |
| Cash From Financing | -$7K | -$1K | -$716K | -$1.8M | -$34.7M | |
| Beginning Cash (CF) | $146.2M | $232.1M | $71.3M | $223.4M | $196.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $12.7M | -$160.5M | $6.3M | $7.8M | -$36.3M | |
| Ending Cash (CF) | $158.8M | $71.6M | $77.7M | $231.2M | $159.9M | |
| Levered Free Cash Flow | $12.3M | -$19.1M | -$18.2M | -$27.1M | -$10.4M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $21.2M | $55.8M | $37.7M | $81.5M | $69.9M | |
| Depreciation & Amoritzation | $22.8M | $23.5M | $23.2M | $23.2M | $20.8M | |
| Stock-Based Compensation | $516K | $1.7M | $2.3M | $6.3M | $3.3M | |
| Change in Accounts Receivable | -$25.1M | $1.7M | -$2.7M | $8.1M | -$9.2M | |
| Change in Inventories | $533K | -$30.2M | $15.1M | $14.2M | -$3.4M | |
| Cash From Operations | $22.4M | $60.5M | $58.5M | $139.7M | $63M | |
| Capital Expenditures | $7M | $5.3M | $18.3M | $58.3M | $53.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$10.3M | -$136.6M | -$34.7M | $19.3M | -$82.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$2.9M | -$4.8M | -$4.7M | -$5.4M | -$3.9M | |
| Cash From Financing | -$18.5M | -$11.1M | -$17.7M | -$5.4M | -$51.3M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$6.4M | -$87.2M | $6.1M | $153.5M | -$71.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $15.5M | $55.1M | $40.2M | $81.4M | $9.6M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $8M | $7M | $6.7M | $12.3M | $10.7M | |
| Depreciation & Amoritzation | $5.9M | $5.9M | $5.8M | $5.9M | $5M | |
| Stock-Based Compensation | $291K | $218K | $612K | $716K | $394K | |
| Change in Accounts Receivable | -$7.9M | $962K | -$6.1M | $2.8M | -$7.4M | |
| Change in Inventories | $11.2M | -$14.2M | $7.4M | -$116K | $1.2M | |
| Cash From Operations | $13.6M | -$17.7M | -$14M | -$2.3M | -$3.5M | |
| Capital Expenditures | $1.3M | $1.5M | $4.2M | $24.8M | $6.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$892K | -$142.8M | $21M | $11.9M | $1.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$32.7M | |
| Other Financing Activities | -$7K | -$1K | -$716K | -$1.8M | -$2M | |
| Cash From Financing | -$7K | -$1K | -$716K | -$1.8M | -$34.7M | |
| Beginning Cash (CF) | $146.2M | $232.1M | $71.3M | $223.4M | $196.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $12.7M | -$160.5M | $6.3M | $7.8M | -$36.3M | |
| Ending Cash (CF) | $158.8M | $71.6M | $77.7M | $231.2M | $159.9M | |
| Levered Free Cash Flow | $12.3M | -$19.1M | -$18.2M | -$27.1M | -$10.4M | |
Get REX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
REX
Sector
P/E ratio
16.53x
11.50x
PEG ratio
0.27x
0.01x
P/B ratio
1.63x
1.01x
Price / LTM sales
1.46x
0.85x
Growth Metrics
REX
Sector
Revenue growth
-1.79%
-0.23%
Earnings growth
-12.07%
-9.79%
Revenue (5-year growth)
8.99%
6.13%
Earnings forecast
$0.34
$0.20
Profitability
REX
Sector
Profitability FY 2024
$91.5M
$92.9M
Return on invested capital
9.07%
3.61%
Return on assets
8.14%
2.38%
Return on equity
9.07%
5.96%
Earnings Date
Last Earnings Date
May
28
Next Earnings Date
Aug
27
Estimated Next Earnings Date
Aug
27
Balance Sheet
REX
Sector
Total cash
$315.9M
$12.9M
Short term investments
$162.8M
$2.9M
Total assets
$720M
$380.4M
Long term debt
--
$122.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
